{"id":996,"date":"2020-09-10T17:53:53","date_gmt":"2020-09-10T17:53:53","guid":{"rendered":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/essai-clinique-plusieurs-centres-sont-actuellement-en-recrutement\/"},"modified":"2026-03-31T15:26:48","modified_gmt":"2026-03-31T15:26:48","slug":"clincial-trial-many-centres-now-recruiting-2","status":"publish","type":"post","link":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/clincial-trial-many-centres-now-recruiting-2\/","title":{"rendered":"ESSAI CLINIQUE \u2013 PLUSIEURS CENTRES SONT ACTUELLEMENT EN RECRUTEMENT"},"content":{"rendered":"<h5>A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients with\u00a0<span class=\"tooltipsall tooltip_post_id_13302 classtoolTips79\" data-hasqtip=\"0\">Advanced Kidney Cancer<\/span><\/h5>\n<p><strong>Trial ID:<\/strong>\u00a0NCT04088500<\/p>\n<p>\u00a0<\/p>\n<p>Voici un essai clinique que tous les patients atteints d\u2019un cancer du rein m\u00e9tastatique devraient savoir s\u2019ils ont re\u00e7u la combinaison nivolumab-ipilimumab au pr\u00e9alable.<\/p>\n<p>L\u2019\u00e9tude veut d\u00e9terminer si cette combinaison peut \u00eatre administr\u00e9e aux patients une deuxi\u00e8me fois, m\u00eame apr\u00e8s avoir arr\u00eat\u00e9 de r\u00e9pondre \u00e0 ce traitement \u00e0 un moment ant\u00e9rieur de leur parcours de soin.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients with\u00a0Advanced Kidney Cancer Trial ID:\u00a0NCT04088500 \u00a0 Voici un essai clinique que tous les patients atteints d\u2019un cancer du rein m\u00e9tastatique devraient savoir s\u2019ils ont re\u00e7u la combinaison nivolumab-ipilimumab au pr\u00e9alable. L\u2019\u00e9tude veut d\u00e9terminer si cette combinaison peut \u00eatre administr\u00e9e aux patients une deuxi\u00e8me fois, m\u00eame [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":997,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"year-of-the-new":[32],"class_list":["post-996","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","year-of-the-new-32"],"_links":{"self":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/comments?post=996"}],"version-history":[{"count":1,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/996\/revisions"}],"predecessor-version":[{"id":998,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/996\/revisions\/998"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media\/997"}],"wp:attachment":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media?parent=996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/categories?post=996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/tags?post=996"},{"taxonomy":"year-of-the-new","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/year-of-the-new?post=996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}